Motus GI (MOTS) Competitors $0.0001 0.00 (0.00%) As of 07/22/2025 12:39 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock MOTS vs. NMRD, UTRS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, GMVDW, and HSCSWShould you be buying Motus GI stock or one of its competitors? The main competitors of Motus GI include Nemaura Medical (NMRD), Minerva Surgical (UTRS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), G Medical Innovations (GMVDW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry. Motus GI vs. Its Competitors Nemaura Medical Minerva Surgical Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care G Medical Innovations Heart Test Laboratories Motus GI (NASDAQ:MOTS) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability. Which has higher earnings & valuation, MOTS or NMRD? Motus GI has higher revenue and earnings than Nemaura Medical. Nemaura Medical is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMotus GI$319K0.00-$12.87M-$15.640.00Nemaura Medical$3.02K2.67-$14.14M-$0.390.00 Does the media favor MOTS or NMRD? In the previous week, Motus GI's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment Motus GI Neutral Nemaura Medical Neutral Do institutionals and insiders have more ownership in MOTS or NMRD? 20.1% of Motus GI shares are owned by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are owned by institutional investors. 0.3% of Motus GI shares are owned by insiders. Comparatively, 40.4% of Nemaura Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more risk & volatility, MOTS or NMRD? Motus GI has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Is MOTS or NMRD more profitable? Company Net Margins Return on Equity Return on Assets Motus GIN/A N/A N/A Nemaura Medical N/A N/A N/A SummaryMotus GI beats Nemaura Medical on 5 of the 8 factors compared between the two stocks. Get Motus GI News Delivered to You Automatically Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MOTS vs. The Competition Export to ExcelMetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$63.83M$5.63B$9.41BDividend YieldN/AN/A4.01%4.02%P/E Ratio0.005.3628.4320.05Price / Sales0.00118.65415.6587.96Price / CashN/A18.4135.9658.29Price / Book0.007.568.525.82Net Income-$12.87M-$24.96M$3.24B$258.18M7 Day PerformanceN/A34.55%4.58%3.68%1 Month PerformanceN/A23.98%12.60%14.51%1 Year PerformanceN/A81.62%35.87%19.00% Motus GI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MOTSMotus GIN/A$0.00flatN/A-99.9%$1K$319K0.0030High Trading VolumeNMRDNemaura Medical1.2304 of 5 stars$0.00flatN/A-99.7%$4K$3.02K0.0040UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160VIVEViveve MedicalN/AN/AN/A-66.7%$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.27+1.1%N/A+7.6%$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.06flatN/A+8.2%$0.00N/A0.002ATAKWAurora Technology AcquisitionN/A$0.02-17.5%N/A+48.5%$0.00N/A0.00N/AGap DownBBLGWBone BiologicsN/A$15.00+11.1%N/A-67.8%$0.00N/A0.002Positive NewsGap UpBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011GMVDWG Medical InnovationsN/AN/AN/AN/A$0.00$4.42M0.0072HSCSWHeart Test LaboratoriesN/A$0.11+45.5%N/AN/A$0.00N/A0.0010Positive NewsGap Up Related Companies and Tools Related Companies NMRD Alternatives UTRS Alternatives VIVE Alternatives DRTSW Alternatives ANZUW Alternatives ATAKW Alternatives BBLGW Alternatives BRSHW Alternatives GMVDW Alternatives HSCSW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MOTS) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motus GI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Motus GI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
